Intellectual Property

  • July 11, 2024

    Va. Jury Invalidates Elevated Stairs Patent Claims

    A federal jury in Virginia has found that claims in an inventor's patent on elevated stairs are invalid, in a win for Mission Integrated Technologies.

  • July 11, 2024

    Fed. Circ. Pauses Ouster Of Teva Patents From Orange Book

    Teva can keep challenged asthma inhaler device patents listed on, and protected by, an important government database after the Federal Circuit agreed Wednesday to pump the brakes on the patents' delisting while the Israeli drugmaker appeals an order won by Amneal in an infringement lawsuit.

  • July 11, 2024

    Security Manager Gave $85M Biz Book To Rival Co., Suit Says

    A former Connecticut regional manager spent days downloading "extensive" data before leaving a security firm for a direct competitor, then gave his new employer millions of dollars' worth of stolen secrets to snipe clients and bolster his chances for earning a lucrative bonus, according to a new suit filed in federal court.

  • July 11, 2024

    GSK Asks Judge To Rule In Teva IP Case, Citing Opioid Deals

    A GlaxoSmithKline lawyer has urged a Delaware federal judge to make up his mind about a nearly $400 million patent case against Teva Pharmaceuticals in light of unrelated "opioid-related cases" that the Israeli generic-drug maker has been settling in the billions of dollars.

  • July 11, 2024

    Chancery Fast-Tracks Blue Cross Data Co. Suit, Denies TRO

    An independent licensee of Blue Cross Blue Shield Association that accused a customer of sharing confidential data with industry competitor Cigna Corp. got its Delaware Chancery Court lawsuit fast-tracked Thursday but failed to get immediate injunctive relief because the harms it alleged were too "speculative."

  • July 11, 2024

    Top Atty At Army Center Of Military History Joins Shook Hardy

    The former chief counsel for the U.S. Army Center of Military History has joined Shook Hardy & Bacon LLP as co-chair of the firm's growing art law practice, the firm announced Thursday.

  • July 11, 2024

    MoFo Lands NY Tech Partner From Goodwin

    Morrison Foerster LLP has added a technology group partner from Goodwin LLP to join its technology transactions group in New York.

  • July 11, 2024

    Patent Cases To Watch In The Second Half Of 2024

    A U.S. Supreme Court case over the reach of the judicially created double patenting doctrine and a dispute over which patents branded drugmakers can list in a federal database are among the cases attorneys will have their eyes on for the rest of the year.

  • July 11, 2024

    Meet Del. Federal Court's Newest Magistrate Judge

    The newest magistrate judge in Delaware's federal district court is a former law clerk to another judge in the courthouse, and also previously served as an intellectual property attorney at Morris Nichols Arsht & Tunnell LLP.

  • July 10, 2024

    Drug Pricing, Overreach Dominate IP Disclaimer Feedback

    The U.S. Patent and Trademark Office has received heated feedback regarding its proposal to make follow-on patents easier to invalidate, with drug pricing advocates applauding it, top technology and pharma companies decrying it, and high-profile officials calling the proposal an overstep of the agency's authority.

  • July 10, 2024

    Ex-Kasowitz IP Pro Says Firm Gave Him Boot, Withheld Pay

    Former Kasowitz Benson Torres LLP partner Jay Deshmukh filed a lawsuit in New York state court against his former firm Tuesday, saying the firm "deliberately" fired him weeks before his one-year anniversary so it could hold back more than half his annual pay.

  • July 10, 2024

    Medical Imaging Co. Looking To Vacate 'Tainted' Award

    A New York federal court has unsealed medical imaging company Molecular Dynamics Ltd.'s still-pending 2022 petition seeking to vacate an allegedly fraudulent arbitral award favoring its former partner in a project to develop cameras in the field of nuclear medicine, revealing more information about the dispute.

  • July 10, 2024

    Roku Wins Transfer Of Patent Suit From WDTX To Calif.

    A Texas federal judge sent to California a case accusing Roku of infringing patents related to automatic content recognition technology for commercial advertising, finding on Wednesday that the ease of access to evidence, location of Roku's witnesses and Roku's headquarters in San Jose weigh in favor of a transfer.

  • July 10, 2024

    Top Banks Accused Of Infringing Authentication IP With Zelle

    Intellectual property licensing outfit Factor2 Multimedia Systems has sued Bank of America, Capital One and others in Texas federal court for allegedly infringing authentication patents with Zelle and other money-transfer apparatuses.

  • July 10, 2024

    Judge Newman Faces More Hurdles In Bid To End Suspension

    With the dismissal of Federal Circuit Judge Pauline Newman's lawsuit against her colleagues over her suspension, experts say she faces significant challenges in securing a different outcome on appeal or persuading the court's other judges to let her hear cases again.

  • July 10, 2024

    Attys Bolt In Groups 'All The Time,' Colo. Judge Says

    A Colorado judge hearing the appeal of an attorney who lost a jury trial in which she was accused of trying to lure colleagues away from a well-known regional personal injury firm noted Wednesday that lawyers commonly leave their firms in groups.

  • July 10, 2024

    ​GOP Bombards Agencies With Demands After Chevron's End

    Republican leaders of major congressional committees Wednesday demanded details from dozens of agencies on policies suddenly shrouded in uncertainty after U.S. Supreme Court conservatives overturned the so-called Chevron doctrine, which for 40 years gave regulators flexibility in rulemaking and advantages in related litigation.

  • July 10, 2024

    Meijer Says Takeda Can't Force Antitrust Suit Into Arbitration

    Meijer argued before a Massachusetts federal court that Takeda waited far too long to try to force the supermarket chain to arbitrate its proposed class action accusing the Japanese pharmaceutical company of conspiring to delay a generic version of its anti-constipation drug Amitiza.

  • July 10, 2024

    Vidal Directs PTAB To Review Nerf 'GelFire' Toy Gun Patents

    The director of the U.S. Patent and Trademark Office has overturned Patent Trial and Appeal Board decisions not to institute reviews of three patents covering Hasbro Inc.'s Nerf "GelFire" toy gun.

  • July 10, 2024

    Pokemon Go Maker Escapes Gaming Patent Suit

    A California federal judge has let the developer of smartphone game Pokemon Go out of a patent infringement suit, deciding that a patent related to augmented reality technology covers an abstract idea.

  • July 10, 2024

    Cheech And Chong's Co. Hits Colo. Cannabis Cos. With IP Suit

    Cheech and Chong's Cannabis Co. has filed an infringement lawsuit against a Colorado entrepreneur, accusing him of using the comedy duo's likeness after being explicitly warned not to, according to a lawsuit filed in Colorado state court.

  • July 10, 2024

    HP Can't Use 'Wex' Name During Pending Trademark Case

    A Maine federal judge has issued a preliminary injunction holding that HP Inc. may not use the word "Wex" for a planned product launch for the duration of trademark litigation brought by financial technology provider Wex Inc., finding that there's a "risk of saturating the market with potential infringement."

  • July 10, 2024

    10th Circ. Now Seems Unsure 'Tiger King' Violated Copyright

    A Tenth Circuit panel that cited the U.S. Supreme Court's Warhol decision in holding that Netflix Inc. could not dodge a copyright complaint for including a funeral video clip in its "Tiger King" docuseries sounded more skeptical about the plaintiffs' arguments during a rehearing Wednesday, grilling counsel about why the short video was not fair use.

  • July 10, 2024

    CBP Clears Apple Watch Of Infringing Heart Monitor IP

    U.S. Customs and Border Protection has ruled that redesigned versions of the Apple Watch do not infringe AliveCor's electrocardiogram patents and can be imported, a decision that comes ahead of a consolidated hearing at the Federal Circuit over the same patents.

  • July 10, 2024

    Buyers Say Teva Had Multipart Scheme To Delay Inhaler Rivals

    Employee benefit funds accusing Teva of orchestrating a decadelong scheme to delay generic competition for its QVAR asthma inhalers told a Massachusetts federal court the drugmaker is trying to end the case by addressing merely one aspect of a multipart scheme.

Expert Analysis

  • The Tricky Implications Of New Calif. Noncompete Laws

    Author Photo

    Two new California noncompete laws that ban certain out-of-state agreements and require employers to notify certain workers raise novel issues related to mergers and acquisitions, and pose particular challenges for technology companies, says John Viola at Thompson Coburn.

  • Patent Ownership Issues In Light Of USPTO AI Guidance

    Author Photo

    Recently published guidance from the U.S. Patent and Trademark Office establishes that inventions created using artificial intelligence may be patentable if a human also significantly contributes, but ownership and legal rights in these types of patents are different issues that require further assessment, says Karl Gross at Leydig Voit.

  • Opinion

    Why USPTO Should Issue Inherency Guidance Memo

    Author Photo

    The U.S. Patent and Trademark Office should issue a new guidance memo in regard to the standard for inherency during the examination process, as the standard is frequently misapplied during prosecution, and consistency of the standard in the USPTO should match that in the federal courts, says Irving Feit at Lucas & Mercanti.

  • Series

    Serving As A Sheriff's Deputy Made Me A Better Lawyer

    Author Photo

    Skills developed during my work as a reserve deputy — where there was a need to always be prepared, decisive and articulate — transferred to my practice as an intellectual property litigator, and my experience taught me that clients often appreciate and relate to the desire to participate in extracurricular activities, says Michael Friedland at Friedland Cianfrani.

  • Fears About The End Of Chevron Deference Are Overblown

    Author Photo

    While some are concerned about repercussions if the U.S. Supreme Court brings an end to Chevron deference in the Loper and Relentless cases this term, agencies and attorneys would survive just fine under the doctrines that have already begun to replace it, say Daniel Wolff and Henry Leung at Crowell & Moring.

  • How Suit Over An AI George Carlin May Lead To Legislation

    Author Photo

    George Carlin’s estate recently sued a company over an artificial intelligence-generated podcast allegedly impersonating the late comedian, highlighting the importance of much-needed state and federal protection against unauthorized representations of an individual’s image in the time of AI, say Anna Chauvet and Maxime Jarquin at Finnegan.

  • Parsing Chinese Governance On AI-Generated Content

    Author Photo

    As essential risk-mitigation, companies with a China reach should be aware of recent developments in Chinese oversight of AI-generated content, including the latest rulings and regulations as well as the updated ambit for supervisory bodies, say Jet Deng and Ken Dai at Dacheng.

  • Negotiating Milestones In Pharma Licenses Requires Care

    Author Photo

    For life sciences companies, understanding the unique issues that arise in licensing agreements' milestone payment provisions can increase the likelihood and amount of payments received by the licensor and ensure payments are carefully and closely tied to events that truly drive value for the licensee, say Edward Angelini at Amneal Pharmaceutical and Lori Waldron at Sills Cummis.

  • Former Minn. Chief Justice Instructs On Writing Better Briefs

    Author Photo

    Former Minnesota Supreme Court Chief Justice Lorie Gildea, now at Greenberg Traurig, offers strategies on writing more effective appellate briefs from her time on the bench.

  • Trending At The PTAB: How Q1 Policymaking Affects Practice

    Author Photo

    Attorneys at Finnegan consider the first quarter's U.S. Patent and Trademark Office policymaking initiatives and how they may affect practice before the PTAB, including a rule that would codify the current pilot program that allows patent owners two opportunities to amend the challenged claims.

  • Stay Interviews Are Key To Retaining Legal Talent

    Author Photo

    Even as the economy shifts and layoffs continue, law firms still want to retain their top attorneys, and so-called stay interviews — informal conversations with employees to identify potential issues before they lead to turnover — can be a crucial tool for improving retention and morale, say Tina Cohen Nicol and Kate Reder Sheikh at Major Lindsey.

  • Direct Claims Ruling May Alter Gov't Ties To Software Firms

    Author Photo

    A recent Federal Circuit decision allowing a software developer to pursue legal action under the Contract Disputes Act could change the government's relationship with commercial software providers by permitting direct claims, even in third-party purchase situations, say Dan Ramish and Zach Prince at Haynes Boone.

  • The Fed. Circ. In February: A Reminder On Procedure Rule 28

    Author Photo

    Because the Federal Circuit does not often issue a sua sponte precedential order emphasizing an important rule of practice, it is useful to look at how the court applied the restrictions of appellate procedure Rule 28 in Promptu v. Comcast last month, and in cases that preceded it, say Jeremiah Helm and Sean Murray at Knobbe Martens.

  • Calif. High Court Ruling Has Lessons For Waiving Jury Trials

    Author Photo

    The California Supreme Court’s recent decision in TriCoast Builders v. Fonnegra, denying relief to a contractor that had waived its right to a jury trial, shows that litigants should always post jury fees as soon as possible, and seek writ review if the court denies relief from a waiver, say Steven Fleischman and Nicolas Sonnenburg at Horvitz & Levy.

  • A Defense Strategy For Addressing Copyright Fee-Shifting

    Author Photo

    Permissive fee-shifting under Section 505 of the Copyright Act poses unique challenges for copyright defendants, carrying an outsize impact on the economic incentive structure in copyright litigation, but relying on a Federal Rule of Civil Procedure may offer a potential solution by allowing defendants to recover attorney fees, say Hugh Marbury and Molly Shaffer at Cozen O'Connor.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!